DAVID F HALE
CIK 1024004 · Chairman · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$159.3K
Companies
8
Total Filings
107
Lifetime Open-Market Net
-$120.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DRMAW | Director | 364 | $0.01 | $4 | $0 | 9 | 2026-01-06 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | 30,387 | $0.53 | $16.0K | -$8.6K | 12 | 2024-06-24 |
| BIOCEPT INC (BIOC) Delisted | Director | 897 | $0.43 | $390 | $197.5K | 17 | 2021-12-10 |
| Histogen Inc. (CNAT) Delisted | Director | 36,363 | — | — | $28.5K | 8 | 2019-07-01 |
| SANTARUS INC (SNTS) Delisted | Director | 315,452 | — | — | $96.2K | 13 | 2013-06-12 |
| Pernix Sleep, Inc. (SOMX) Delisted | Director | 110,486 | — | — | -$289.6K | 25 | 2013-01-03 |
| MICROMET, INC. (MITI) Delisted | Director | 139,062 | — | — | -$168.3K | 15 | 2012-03-06 |
| MBRX | Director | 60,337 | $2.64 | $159.3K | $23.4K | 5 | 2009-06-25 |
Recent Filings · Page 3 of 11
107 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-12 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-09 | BIOCEPT INC (BIOC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-22 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Buy (P) | +17,412 | $0 | EDGAR |
| 2019-09-16 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-01 | Histogen Inc. (CNAT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-19 | BIOCEPT INC (BIOC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-11 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | +717,752 | $0 | EDGAR |
| 2018-07-02 | BIOCEPT INC (BIOC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-25 | Histogen Inc. (CNAT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-26 | Histogen Inc. (CNAT) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.